Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency.
Saved in:
| Title: | Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency. |
|---|---|
| Authors: | Kim O; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Butler M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Sergi Z; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Robey RW; Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Zhang M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Chari R; Genome Modification Core laboratory, Leidos Biomedical Inc/ Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Pang Y; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Yu G; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Zhang W; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Song H; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Davis D; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Hawley RG; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Wen X; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Wang H; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Quezado M; Laboratory of Pathology., Tran B; Sequencing Facility, Leidos Biomedical Inc/ Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Merchant M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Ranjan A; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Furnari FB; University of California at San Diego, School of Medicine, La Jolla, California, USA., Khan J; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Ryan Miller C; The University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA., Gottesman MM; Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Pommier Y; Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Wu J; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2023 Aug 21; Vol. 5 (1), pp. vdad102. Date of Electronic Publication: 2023 Aug 21 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-2498 |
|---|---|
| DOI: | 10.1093/noajnl/vdad102 |
